NFKB1 and Hyperglycemia: The experimental groups that received the extract at doses of 50, 100, and 200 mg/kg body for 10 days presented a reduction in proteinuria, hyperglycemia, renal advanced glycation end-product (AGE) formation, and the expression of related proteins, such as the receptor for AGEs, nuclear factor-κB (NF-κB), transforming growth factor-β1, and Nε-(carboxymethyl)lysine [138].